Tadalafil Side Effects
Some side effects of tadalafil may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to tadalafil: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking tadalafil: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
If you become dizzy or nauseated during sexual activity, or if you have pain, numbness, or tingling in your chest, arms, neck, or jaw, stop and call your doctor right away. You could be having a serious side effect of tadalafil.
Stop using tadalafil and call your doctor at once if you have any of these serious side effects:
changes in vision or sudden vision loss;
ringing in your ears, or sudden hearing loss;
chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
shortness of breath, swelling in your hands or feet;
feeling light-headed, fainting; or
penis erection that is painful or lasts 4 hours or longer.
Less serious side effects of tadalafil may include:
redness or warmth in your face, neck, or chest;
cold symptoms such as stuffy nose, sneezing, or sore throat;
diarrhea, upset stomach; or
muscle pain, back pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to tadalafil: oral tablet
Cardiovascular side effects have included angina pectoris, chest pain, hypotension, hypertension, myocardial infarction, postural hypotension, palpitations, syncope, and tachycardia.
Dermatologic side effects have included pruritus, rash, and sweating.
Gastrointestinal side effects have included dyspepsia, diarrhea, dry mouth, dysphagia, esophagitis, gastroesophageal reflux, gastritis, loose stools, nausea, upper abdominal pain, and vomiting.
General side effects have included asthenia, face edema, facial flushing, fatigue, and pain in a limb.
Genitourinary side effects have included increased erection and spontaneous penile erection.
Hepatic side effects have included abnormal liver function tests such as an increased GGTP.
Musculoskeletal side effects have included back pain or myalgia, arthralgia, and neck pain.
Respiratory side effects have included nasal congestion, dyspnea, epistaxis, pharyngitis, nasopharyngitis, upper respiratory tract infection, and bronchitis.
Nervous system side effects have included headache, dizziness, hypesthesia, insomnia, paresthesia, somnolence, migraine and vertigo. Postmarketing experience has included seizure and seizure recurrence and transient global amnesia.
Ocular side effects have included blurred vision, changes in color vision, conjunctivitis (including conjunctival hyperemia), eye pain, increased lacrimation, and swelling of the eyelids.
Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including tadalafil.
Other side effects have included cases of sudden decrease or loss of hearing reported postmarketing in temporal association with the use of PDE5 inhibitors, including tadalafil. In some cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of tadalafil, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors.
Hypersensitivity side effects have included Stevens-Johnson syndrome and exfoliative dermatitis.
More tadalafil resources
- tadalafil MedFacts Consumer Leaflet (Wolters Kluwer)
- tadalafil Advanced Consumer (Micromedex) - Includes Dosage Information
- Tadalafil Professional Patient Advice (Wolters Kluwer)
- Tadalafil Monograph (AHFS DI)
- Adcirca Prescribing Information (FDA)
- Adcirca Consumer Overview
- Adcirca MedFacts Consumer Leaflet (Wolters Kluwer)
- Cialis Prescribing Information (FDA)
- Cialis Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.